Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Clinical trial NCT00106353 · COMPLETED

Trial details

NCT number: NCT00106353
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Neoplasms

Start date: 2005-03-01
Primary completion: 2009-10-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.